Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if NXTC is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
13 top institutions tracked
Last 13F trend: distributing (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: bullish
Last trade: sell 64 days ago
Red flags: 0
30 filers reported a long position in NXTC for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Ikarian Capital, LLC | $461.3K | 288.3K | +21% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $443.5K | 277.2K | New |
| Sofinnova Investments, Inc. | $356.2K | 222.7K | Unchanged |
| RENAISSANCE TECHNOLOGIES LLC | $273.9K | 171.2K | +182.8% |
| VANGUARD CAPITAL MANAGEMENT LLC | $250.9K | 156.8K | -2.3% |
| MILLENNIUM MANAGEMENT LLC | $141K | 88.1K | New |
| BOOTHBAY FUND MANAGEMENT, LLC | $135.5K | 84.7K | +21.6% |
| Squadron Capital Management LLC | $103.1K | 64.5K | -75.7% |
| Verdad Advisers, LP | $96.7K | 60.5K | +40.7% |
| PFIZER INC | $73K | 44.3K | -71.1% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.